Attach 10 - AsiaLymph Study Organization

Attach 10 - AsiaLymph Study Organization.doc

A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph) (NCI)

Attach 10 - AsiaLymph Study Organization

OMB: 0925-0654

Document [doc]
Download: doc | pdf



Attachment 10:

Overview of the AsiaLymph study organization and key personnel in Asia






















Head of Study Coordinating Center


Tai Hing Lam,

Chair Professor and Head of Department,

School of Public Health,

University of Hong Kong,

Pokfulam Rd., Sai Ying Poon, Hong Kong,

Tel: (852) 2819 9287

Email: hrmrlth@hkucc.hku.hk



Head of Study Pathology Center


John K.C. Chan,

Consultant Pathologist and Director of Anatomical Pathology,

Queen Elizabeth Hospital,

Wylie Road, Kowloon, Hong Kong,

Tel: (852) 2958 6830

Email: jkcchan@ha.org.hk



Study Center Leaders


Yok-Lam Kwong,

Director and Professor,

Bone Marrow Transplant Unit,

Queen Mary Hospital, Hong Kong University

102 Pok Fu Lam Road, Hong Kong,

Tel: (852) 2855 4597

Email: ylkwong@hkucc.hku.hk


Caigang Xu,

Associate Professor,

Department of Hematology,

Sichuan University West China Hospital

37# Guoxuexiang, Chengdu, Sichuan, China 610041,

Tel: (86)28 8542 2366

Email: xucaigang@yahoo.com


Kexin Chen,

Director, Department of Epidemiology and Biostatistics,

Tianjin Medical University Cancer Institute and Hospital,

Tianjin Medical University

Qixiangtai Road, Hexi District, Tianjin, China 300060,

Tel: (86)22 23372231

Email: Chenkexin1963@yahoo.com


Yu-Chieh Su,

Division of Hematology-Oncology, Department of Internal Medicine,

Dalin Tzu-Chi General Hospital,

No.2, Ming-Shen Road, Dalin Town, Chia Yi County, Taiwan, POC 622,

Tel: (886)5 2648128

Email: hepatoma@gmail.com



3


File Typeapplication/msword
File TitleProposal for a multi-center hospital-based case-control study of non-Hodgkin lymphoma and related malignancies
Last Modified ByVivian Horovitch-Kelley
File Modified2012-02-23
File Created2012-02-21

© 2024 OMB.report | Privacy Policy